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Abstract 
Introduction 
Chris Hani Baragwanath (CHB) hospital has 20 000 deliveries per annum, with 25% 
by caesarean section (CS). Therefore, vaginal birth after caesarean section (VBAC) is 
an important delivery option. We questioned the reasons for the low VBAC success 
following trial of labour (TOL). The primary objective was to determine the 
proportion of eligible patients attempting TOL and the VBAC success rate. Secondary 
objectives were to establish reasons for failed VBAC, predictive factors for VBAC, 
and maternal and neonatal morbidity and mortality. 
Methodology 
A retrospective descriptive study by record review, analysing demographic, obstetric 
and delivery outcome variables of women with one prior CS in a subsequent 
pregnancy. 
Results 
From the 340 patients eligible for VBAC, 287 (84.4%) attempted TOL and 53 
(15.6%) had an elective repeat caesarean section (ERCS). VBAC success was 51.6% 
(148/287). Prelabour rupture of membranes and prolonged latent phase of labour 
resulted in 40% of failed VBAC. Successful VBAC was associated with a higher 
parity, lower birth weight and lower gestation (p<0.001). Positive predictors of 
successful VBAC were previous vaginal birth (p=0.004), previous VBAC (p=0.038), 
previous CS for malpresentation (p=0.012), birth weight <3500g (p=0.003), and 
gestation ≤ 39 weeks (p<0.001). Negative predictors were previous CS for cephalo-
pelvic disproportion (p=0.003) and women with no prior vaginal deliveries (p<0.001). 
There was no maternal mortality. Complications however, included 2 uterine ruptures, 
2 uterine dehiscences, 4 hysterectomies, and one intrapartum fetal death. Adverse 
maternal outcomes were increased with TOL compared to ERCS (p=0.038), and more 
so with failed compared to successful VBAC (p=0.002). Adverse neonatal outcomes 
were also increased with TOL compared to ERCS (p=0.048), however there was no 
difference in neonatal outcomes between failed and successful VBAC (p=0.420). 
Conclusion 
VBAC remains a viable option for patients with one prior CS in this setting, despite a 
lower VBAC success than developed countries. Failed VBAC due to prelabour 
rupture of membranes and prolonged latent phase of labour remains a problem.  
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Definition of terms 
Augmentation 
of labour 
The administration of oxytocin during the first stage of labour to women with 
poor progress, due to inadequate or inefficient uterine contractions. 
CPD 
Relative or absolute disproportion between the fetal head size and the maternal 
pelvis (due to fetal macrosomia, contracted maternal pelvis, or malposition of 
the fetal head during labour), resulting in failure of normal progress of labour. 
EmCS 
Repeat caesarean section, in patients with prior caesarean section following   
(1) an acute event that precludes conservative management or elective delivery 
at a later stage, (2) patients presenting in spontaneous labour, while having 
contra-indications to vaginal birth after caesarean section. 
ERCS Planned elective caesarean delivery in patients with prior caesarean section. 
Failed VBAC 
Patients that attempted a trial of labour, but eventually required caesarean 
delivery (due to prelabour rupture of membranes, prolonged latent phase of 
labour, poor progress in the active phase of labour, prolonged second stage of 
labour, fetal or maternal compromise). 
PLPL Latent phase of labour (0-3cm cervical dilatation) that lasts more than 8 hours. 
Poor progress  
in active  
labour 
Labour progresses slowly as determined by an increase in cervical dilatation of 
less than 1cm an hour (i.e. crossing the alert line of the Partogram). 
PROM 
Rupture of the amniotic membranes, with confirmed drainage of amniotic fluid, 
prior to the onset of labour contractions. 
Poor progress 
in 2nd stage of 
labour 
Delivery has not occurred after 30 minutes of active maternal pushing in a 
multiparous patient, or 45 minutes in a primparous patient, and the patient is 
not suitable for an assisted vaginal delivery by forceps or vacuum extraction. 
Successful 
VBAC 
Vaginal delivery of the fetus (spontaneous, and forceps or vacuum assisted 
delivery), following an attempted trial of labour. 
TOL 
An attempt at vaginal delivery by patients with a prior caesarean section, with 
careful maternal and fetal monitoring, for the signs of uterine rupture or other 
maternal and fetal complications of labour. 
Uterine 
dehiscence 
Disruption of the uterine muscle with intact uterine serosa. It is often 
asymptomatic and found at the time of operative delivery in patients with prior 
caesarean section. 
Uterine 
rupture 
Disruption of the uterine muscle extending to the uterine serosa, the bladder or 
the broad ligament. It is associated with a trial of labour and results in acute 
maternal and fetal compromise, necessitating an emergency laparotomy. 
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1. Introduction 
 
1.1 Literature Review 
The widespread use of caesarean section (CS), the operative abdominal delivery of a 
neonate for various indications, has forever changed current worldwide obstetric 
practice. However, ongoing controversy, around what is today one of the commonest 
operative procedures in modern medicine, has been raging for at least 500 years.  
 
CS (often referred to as caesarean delivery or birth) is thought to have begun as a 
postmortem procedure during the Roman era. Lex cesarea was the law that mandated 
burial of the dead mother and fetus in separate graves. There is little evidence about 
the reported abdominal delivery of newborns from Greek Mythology, ancient Hindu, 
Egyptian and Chinese folklore (Drife 2002). The first documented survivor of CS was 
Elizabeth Nufer in 1500. Jacob Nufer, a Swiss pig gelder, performed a CS out of 
desperation (and with some anatomical knowledge and equipment he had gathered 
after years of slaughtering pigs), on his wife who had unsuccessfully laboured for 
several days. The child reportedly survived, and Elizabeth went on to deliver a further 
4 singletons and one set of twins vaginally (Reiss 2003). 
 
Sporadic reports of CS continued for the next 300 years. Following Nufer’s success, 
Francois Roussett described 14 CS in 1581 (Sedhev 2005). Further operative 
deliveries were performed where the mother had survived by Mary Donally (1738) in 
Ireland, Dr James Barlow (1793) in England, James Miranda Barry (1821) in South 
Africa and Dr John Richmond (1827) in America. Although it was known that CS had 
been carried out by indigenous healers in Africa for many years, no documentation is 
available (Drife 2002). However, a British traveler to Africa in 1879, RW Felkin, 
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reportedly witnessed a CS performed by indigenous healers on a live women who 
subsequently survived, in Kahura, Uganda. There were apparently similar reports 
from Rwanda (“Cesarean section- A brief history” NIH). 
 
All of these operations were carried out without anaesthesia and were often combined 
with hysterectomy. Death from haemorrhage or sepsis was the norm. In the 1846 
diethyl ether was introduced at the Massachusetts General Hospital. Britain’s Queen 
Victoria was the famous survivor of two CS deliveries, with children Leopold (1853) 
and Beatrice (1857). Even though the technique of asepsis was introduced in the 
1870s by Lister, CS mortality remained high. Sedhev quotes Radford’s description, in 
1880, of a series of 131 CS with an 83% mortality rate. Max Sanger then described 
the benefit of suturing the uterine incision in 1882 (using silver wire and silk). He 
documented the survival of 8 out of 17 mothers in various American hospitals 
(Sedhev 2005). 
 
While internal suturing decreased haemorrhagic morbidity and mortality, 
extraperitoneal CS described by Frank (1907) and adapted by Latzko (1909) helped to 
decrease peritoneal sepsis. Up to this point all CS were “classical” vertical incisions in 
the upper uterine fundus. Krönig realized, in 1912, that the extraperitoneal approach 
allowed a safer vertical incision in the thinner lower uterine segment. Beck (1919) and 
De Lee (1922) modified this incision. In 1926, Munro Kerr finally described the 
transverse lower uterine incision CS (TLCS) that is still used today. TLCS has the 
benefits of reduced haemorrhage and peritonitis when compared to a classical CS. 
With the discovery of penicillin by Alexander Fleming in 1928, and its availability by 
1940, the extraperitoneal CS was no longer necessary (Sehdev  2005). 
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 Up to this point the dictum of “once a caesarean, always a caesarean” established by 
Edwin Craigin in 1916, was generally accepted. The number of women delivered by 
CS continued to grow worldwide as surgical training, anaesthesia, antibiotics and 
facilities steadily improved. Craigin however, made his statement at a time when 
classical CS was the norm. In 1923, Schell described vaginal birth after caesarean 
delivery (VBAC), but the practice of elective repeat caesarean section (ERCS) 
persisted. ERCS in patients with a prior CS continued to contribute to the overall CS 
rate, which eventually peaked in the 1980s. 
  
VBAC was then encouraged on a large scale in an attempt to decrease the overall CS 
rate. This was supported by a study, involving 5733 patients with a prior CS opting 
for a trial of labour (TOL), carried out at 11 centres in California, USA (Flamm 
1990). VBAC success in this study was 75%, with no maternal deaths in the TOL 
group. Perinatal mortality was similar to that of the general obstetric population.  
 
Rosen (1991) reported a meta-analysis of 31 studies between 1982 and 1989, with 11 
417 patients with prior CS having TOL, to evaluate maternal and neonatal morbidity 
and mortality associated with VBAC. It was concluded that oxytocin use, recurrent 
indication for previous CS, and an unknown previous uterine scar were not associated 
with uterine rupture or dehiscence. The meta-analysis also found that although the 
five-minute Apgar scores were lower in the TOL group of patients, the perinatal 
morbidity rate was not statistically different. Rosen therefore promoted VBAC. 
 
However, the assumption that increasing VBAC deliveries would safely reduce 
overall CS rates was being increasingly challenged. Although there were no large 
randomised controlled trials comparing VBAC and ERCS, the data from large series 
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and meta-analyses indicated that the relative risk of uterine rupture, maternal 
morbidity, and severe perinatal morbidity or mortality, was increased in women 
undergoing TOL rather than ERCS. This risk appeared to be higher in patients who 
attempted TOL and failed, resulting in an emergency repeat CS (EmCS). Morbidity 
and mortality seemed to revolve around uterine rupture (McMahon 1996, Rageth 
1999, Mozurkewich 2000, Kieser 2002, Smith 2002, Bujold 2002, Chauhan 2003, 
Landon 2004 and Shi Wu Wen 2004). 
 
Uterine rupture is the rare but serious complication in subsequent pregnancies 
following a prior CS. The incidence is 0.2–1.5% after a TLCS, 1–1.6% after a vertical 
lower segment CS, and 4–9% after a classical or ‘inverted-T’ incision CS (NICE 
guideline 2004). The overall risk of uterine rupture or dehiscence in patients having 
TOL is 3.5 per 1000, compared to 1.2 per 1000 for those with ERCS. The risk of 
neonatal death with TOL is one per 1000, which is ten times higher than the rate for 
ERCS of 0.1 per 10 000 (NICE guideline 2004). 
 
The first of the studies that identified a problem with the policy of VBAC to reduce 
overall CS rates, was a population-based study in Nova Scotia, Canada (McMahon 
1996). Among 82 488 births from 1986 to 1992, of which 6 138 patients had a prior 
TLCS, 3249 patients underwent TOL compared to 2889 who had ERCS. The VBAC 
success rate was 60.4%, while the uterine rupture rate was 0.3%. Major maternal 
complications including hysterectomy, uterine rupture or operative injury were almost 
twice as likely in the TOL group (odds ratio (OR) 1.8; 95% confidence interval (CI) 
1.1 to 3.0). Five-minute Apgar scores, neonatal intensive care unit (ICU) admissions, 
and perinatal mortality were similar in the TOL and ERCS groups. In this study age 
less than 35 years, a birth weight of less than 4000g, and delivery at a tertiary care 
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facility resulted in a greater likelihood of a successful VBAC. McMahon concluded 
that selection of women with a high probability of vaginal delivery after TOL was 
essential to decrease the overall risk of TOL.  
 
The second study (cross sectional) looked at a pooled database of 457 825 deliveries 
in Switzerland, including 29 046 patients with prior CS (Rageth 1999). In 17 613 
patients attempting TOL, there was a 73.7% VBAC success rate. The risk of uterine 
rupture in the TOL group was double that of the ERCS group (relative risk (RR) of 
2.07; 95% CI 1.29-3.30). In this study uterine rupture was associated with induction 
of labour, epidural anaesthesia, failure to progress and an abnormal fetal heart rate 
pattern. In contrast to McMahon’s study however, all other maternal risks were lower 
in the TOL group (including hysterectomy, RR 0.36; 95% CI 0.23-0.56).  
 
The third study, a meta-analysis from 1989 to 1999 (Mozurkewich 2000), looked at 
indicators of both maternal and neonatal morbidity and mortality. Fifty-two studies 
from developed countries were identified. Only 15 studies were included because 
many of the subjects in the control group (ERCS patients) in the remaining 37 trials 
were not eligible for TOL. A total of 47 682 patients was included. Patients having 
TOL had a two-fold increase in the rate of uterine rupture (OR 2.10; 95% CI 1.45-
3.05) compared to patients having ERCS, but were less likely to have febrile 
morbidity (OR 0.70; 95% CI 0.64-0.77), require a blood transfusion (OR 0.57; 95% 
CI 0.42-0.76) or have a hysterectomy (OR 0.39; 95% CI 0.27-0.57). The meta-
analysis showed that there was no difference in maternal mortality between the ERCS 
and TOL patients. Fetal or neonatal death was more frequent in TOL (OR 1.71; 95% 
CI 1.28-2.28) and a low five-minute Apgar score was twice as likely in the TOL 
group (OR 2.24; 95% CI 1.29-3.88). This meta-analysis showed that the increased 
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likelihood of uterine rupture in TOL appeared to adversely affect neonatal outcomes 
rather than cause an increase in other adverse maternal events.  
 
Some of the previous studies did not clearly distinguish between a uterine rupture and 
a uterine dehiscence. A population-based study by Kieser (2002) showed that uterine 
rupture and dehiscence occurred with the same frequency (2.4 per 1000), but only 
uterine rupture was associated with maternal morbidity (blood transfusion) and 
neonatal asphyxia. 
 
The fourth study, demonstrating the dangers of TOL, was a Scottish population-based 
longitudinal study from 1992 to 1997 (Smith 2002). This study included 313 238 
singleton, term, cephalic births and 15 515 TOL. This study showed that TOL had an 
eleven times higher risk of perinatal death (OR 11.6; 95% CI 1.6-86.7) compared to 
ERCS. Although the absolute risk was low (12.9 per 10,000 for TOL compared to 1.1 
per 10,000 for ERCS), this was still double the risk of perinatal death in multiparous 
women without a prior CS (OR 2.2; 95% CI 1.3-3.5) and higher than that in 
primiparous women (OR 1.3; 95% CI 0.8-2.1). Prompt intervention, with emergency 
CS after uterine rupture, did not always prevent severe neonatal morbidity or death 
(Bujold 2002). 
 
Chauhan (2003) subsequently carried out an extensive literature review of articles 
from 1989 to 2001. Seventy two out of 361 articles looked specifically at maternal 
and perinatal complications of uterine rupture in sufficient detail and numbers. The 
overall rate of uterine rupture associated with TOL was 6.2 per 1000 (880/142 075). 
This meta-analysis showed that uterine rupture related complications per 1000 
attempted TOL was: 1.8 for blood transfusion, 1.5 for fetal asphyxia (cord pH<7.00), 
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0.9 for hysterectomy, 0.8 for genitourinary injury, 0.4 for perinatal death and 0.02 for 
maternal death. Chauhan concluded that although uncommon, adverse outcomes 
related to uterine rupture during TOL were dependant on the time of the publication, 
site of study, and size of the population studied. 
 
All studies alluded to previously, were retrospective or population-based longitudinal 
cohort studies. Therefore, the large prospective cohort study by Landon (2004) was 
unique. This was carried out at 19 academic centres in the USA from 1999-2002, and 
reported on the primary outcomes of 33 699 patients from a total of about 46 000 
patients with a prior CS. Those with a clear indication for ERCS were excluded. The 
study finally compared 17 898 TOL with 15 801 ERCS, with a reported 73.4% VBAC 
success rate. There was a 0.7% symptomatic uterine rupture rate for TLCS and a 2.0% 
rate for a previous vertical lower segment CS.  
 
Landon found that uterine rupture was associated with the use of oxytocin 
augmentation of labour, and induction of labour by any means. Hysterectomy and 
maternal morbidity were not different between the two groups. However, endometritis 
and blood transfusion were more frequent with TOL patients. TOL had double the 
risk of an adverse maternal event when compared to ERCS (OR 1.96; 95% CI 1.73-
2.22). Furthermore, a greater perinatal risk was associated with TOL (hypoxic 
ischaemic encephalopathy - 0.46 per 1000 TOL’s compared to none for ERCS). The 
corrected perinatal death rate (stillbirths and neonatal deaths excluding congenital 
malformations) was 4.0 per 10,000 for the TOL group and 1.4 per 10,000 in the ERCS 
group. 
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The retrospective Canadian study of 308 755 patients with a previous CS (Shi Wu 
Wen 2004), showed that ERCS was associated with a higher rate of in-hospital deaths 
(5.6 maternal deaths per 100,000 ERCS versus one maternal death per 100,000 TOL). 
This study concluded that while TOL results in more uterine ruptures (0.65%), blood 
transfusions (0.19%) and hysterectomies (0.10%), ERCS patients might have an 
increased risk of maternal death. 
 
With the danger of uterine rupture and the implications for maternal and neonatal 
morbidity and mortality well established, the number of patients attempting TOL 
began to fall by the mid 1990s, with resurgence in ERCS births in patients with a prior 
CS by 2002 (Greene 2004, ACOG bulletin no.54, 2004). 
 
The key to the dilemma of mode of delivery for patients with a prior CS lies in 
identifying those patients who are most likely to succeed at TOL, with the lowest 
likelihood of uterine rupture. This brings us to the studies that attempt to identify 
factors that might be predictors of VBAC success, and factors that are less likely to be 
associated with uterine rupture. 
 
A previous vaginal delivery, before or after the index CS, is one such factor. Zelop 
(2000) demonstrated a five fold decrease (OR 0.2; 95% CI 0.04-0.8) in uterine rupture 
for women with a prior CS delivering at term (0.2%), who also had one or more 
previous vaginal deliveries, when compared to  those who did not have a previous 
vaginal delivery and attempted TOL (1.1%). Furthermore, Macones (2005) 
encouraged women with a previous vaginal delivery prior to the first CS, to attempt 
TOL in the subsequent pregnancy, after showing a reduced risk of uterine rupture (OR 
0.40; 95% CI 0.20-0.81) in this subgroup.  
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A retrospective cohort study in Pennsylvania, USA, from 1994 to 1999, of 9 960 
women with a singleton gestation and one prior CS, analysed the effect of previous 
vaginal delivery on VBAC success with TOL (Elkousy 2003). The overall VBAC 
success was 74%. This rate was studied independently for women with no prior 
vaginal deliveries, those with a previous VBAC after the first CS, those with a 
previous vaginal delivery before the first CS and lastly women who had both a 
previous vaginal delivery before and a previous VBAC after the initial CS. VBAC 
success was 65%, 94%, 83% and 93% respectively. In the first group (women with no 
prior vaginal deliveries) VBAC success was further decreased if the indications for 
previous CS were cephalo-pelvic disproportion (CPD) or failure to progress, or if 
induction or augmentation of labour was used during the TOL. 
 
Cahill (2006) carried out a retrospective cohort study, at 17 centres in Washington, 
USA, from 1996 to 2000. The study included 6 619 patients with a prior CS and a 
previous vaginal delivery, with 5 041 attempting TOL and 1 578 having ERCS. TOL 
in this subgroup of patients resulted in no increase in uterine rupture or bladder injury, 
and lower rates of maternal pyrexia and blood transfusion.  
 
When looking at other factors that possibly influence VBAC success and uterine 
rupture, induction and augmentation of labour appears to increase the risk of uterine 
rupture in TOL. This was reported in several studies (Lydon-Rochelle 2001, 
Blanchette 2001, Macones 2005, and Landon 2005).  
 
A longitudinal, population-based study from 1987 to 1996 in Washington, USA, 
looked at 20,095 women with a prior CS who had a second singleton delivery within 
the same defined period (Lydon-Rochelle 2001). Those that delivered by ERCS had a 
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rate of uterine dehiscence of 1.6 per 1000 deliveries. Spontaneous TOL had a 3-fold 
increase in uterine ruptures (5.2 per 1000), induction of labour (IOL) had a 5-fold 
increase (7.7 per 1000), and IOL with prostaglandin a 15 fold increase in uterine 
rupture (24.5 per 1000). Similarly, a study at a community-based hospital in 
Massachusetts, USA, found that 11 out of 12 uterine ruptures from 754 TOL involved 
either induction, augmentation or both (Blanchette 2001). 
 
More recently, Macones (2005) suggested that prostaglandins alone were not 
associated with uterine rupture, but the sequential use of prostaglandins and then 
oxytocin increased the chances of a uterine rupture (adjusted OR of 3.07; 95% CI 
0.98-9.88). A guideline from the Society of Obstetricians and Gynaecologists of 
Canada (SOGC) (no.155, 2005) does not consider oxytocin augmentation to be a 
contraindication in TOL. However, in their Practice bulletin (no.54, 2004) the 
American college of Obstetricians and Gynaecologists (ACOG) discourages the use 
of prostaglandins for cervical ripening, but does not categorically state that oxytocin 
augmentation is contraindicated in VBAC. The ACOG concludes however, that the 
rate of uterine rupture is not greater in patients attempting VBAC who receive 
oxytocin, when compared to those who labour spontaneously.  
 
The next factor that might be a predictor of VBAC success is birth weight. Zelop 
(2001) reported on a study from New York, USA, that included 2 749 patients at term 
with one previous CS and no prior vaginal deliveries, who attempted TOL. Women 
with a neonatal birth weight >4000g had an OR of 1.7 (95% CI 1.3-2.2) of having a 
failed VBAC and EmCS. The overall VBAC success however remained at least 60% 
provided the birth weight was <4250g. This study reported no increase in uterine 
rupture during TOL with these macrosomic babies compared to those <4000g. 
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Elkousy (2003) however, reported that while women with macrosomic infants still 
had a 60-90% chance of a successful VBAC, uterine rupture was increased in those 
without a previous vaginal delivery (RR of 2.3; p<0.001). 
 
Factors affecting VBAC success were analysed in a large, multi-centred, prospective 
observational study conducted between 1999 and 2002, in the USA. (Landon 2005).  
This study looked at 14 529 patients with TOL, with a 73.6% VBAC success rate. 
Predictors of successful VBAC included a previous vaginal delivery before or after 
the prior CS (OR 3.9; 95% CI 3.6-4.3), indication for previous CS other than dystocia 
(OR 1.7; 95% CI 1.5-1.8), spontaneous labour (OR 1.6; 95% CI 1.5-1.8), and a birth 
weight of less than 4000g (OR 2.0; 95% CI 1.8-2.3). Negative predictors of VBAC 
success were a maternal body mass index (BMI) of more than 30, induction of labour, 
and the lack of a previous vaginal delivery. 
 
A secondary analysis of a prospective observational study compared the outcomes of 
14 142 women attempting TOL with 14 304 having ERCS (Hibbard 2006). This study 
reported that an increased maternal BMI was directly associated with failed VBAC 
(15.2% with BMI 18.5 to 24.9 compared to 39.3% for a BMI of 40.0 or more). 
Morbid obesity (BMI >40) was also a significant risk factor for uterine rupture or 
dehiscence (5 fold increase), composite maternal morbidity (2 fold increase) and 
neonatal injury (5 fold increase in fractures, brachial plexus injuries and lacerations). 
 
A retrospective cohort study (1996 to 2000), of 25 005 patients, was carried out in 
Philadelphia, USA, to assess the impact of maternal age on VBAC success (Srinivas 
2007). A total of 13 706 women (54.8%) attempted TOL. Women aged 15 to 20 were 
less likely to have a failed VBAC (OR 0.73; 95% CI 0.62-0.87). Women aged 35 
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years or older were more likely to have a failed VBAC attempt (OR 1.14; 95% CI 
1.03-1.25), and more likely to have VBAC-related operative complications (OR 1.39; 
95% CI 1.02-1.89).  
 
A South African study, from Bloemfontein, with a similar setting to our own (i.e. a 
tertiary referral and teaching hospital in the public sector) looked at delivery outcomes 
in 189 patients with a previous CS (Van der Walt 1994). In this study, 79.4% of 
women attempted TOL and 56.7% had a successful VBAC. There was a 2% uterine 
rupture rate (4/189), one maternal and two perinatal deaths. Van der Walt concluded 
that TOL with a neonatal birth weight of >3200g, or a previous CS for CPD, were risk 
factors for failed VBAC. Emergency CS after a failed VBAC was the only significant 
risk factor associated with maternal morbidity. 
 
 In addition, Van der Walt (1994) discussed 10 publications addressing VBAC in 
developing countries, between 1987 and 1991. This meta-analysis of 5 458 patients 
showed a VBAC attempt rate of 54.2%, and a VBAC success rate of 64.5%. There 
was a 2% uterine rupture rate and 5.98 maternal deaths per 10,000 TOL attempts. The 
study concluded that VBAC success was relatively low in developing countries. 
  
A recent publication (Tripathi 2006), also from a developing world setting in 
Ahmedabad, India, in a study of 81 patients, identified previous CS for 
malpresentation or fetal distress, and previous vaginal birth as factors associated with 
an increased VBAC success rate. They described a low likelihood of successful 
VBAC at a birth weight of more than 3000g and in patients receiving induction or 
augmentation of labour. The overall success rate however, was 73%. 
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Deutchman (2003) summarised factors that increased the chance of successful VBAC 
with TOL. These factors could help in the appropriate selection of patients for TOL. 
These included: absence of the prior indication for CS; absence of CPD; spontaneous 
onset of labour with an initial cervical dilatation of 3 to 4 cm; absence of induction 
(particularly with prostaglandins) or augmentation of labour; birth weight <4000g; the 
presence of one previous normal delivery or one previous VBAC; a previous 
transverse lower uterine segment CS; and a highly motivated patient who has been 
fully counselled about the risks of uterine rupture. This editorial concluded however, 
that there was a lack of reliable predictors of uterine rupture. 
 
Macones (2006) recently developed a clinical predictive model for uterine rupture in 
TOL, using antenatal parameters, and then antenatal combined with early intrapartum 
factors. Unfortunately, both the combined clinical indices and individual predictive 
indices had poor sensitivity and specificity. This means that while we may be able to 
choose suitable patients for TOL who have a lower likelihood of uterine rupture, we 
cannot predict which patient is at risk of this rare but catastrophic event. 
 
Evidence from prospective randomised controlled trials, to predict which patients are 
likely to have a successful VBAC (with the least potential for maternal and neonatal 
morbidity and mortality) remains elusive. At present, it seems unlikely that any 
patient population will consent to a large-scale randomised control trial, comparing 
ERCS and TOL, in order to clarify these concerns. A systematic review by Dodd and 
Crowther (2004) concluded that future controlled trials without randomisation, cohort 
or case controlled studies, could still offer better quality evidence by ensuring 
comparability of groups and reporting on precise and standard outcomes.  
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For the present time however, it remains the responsibility of health care providers to 
individualise delivery options for patients with prior CS, taking local resources and 
expertise into consideration. The mode of delivery must be decided upon after full 
informed consent from the patient, with regard to the potential risks and benefits of 
both TOL and ERCS.  
 
1.2 Background 
Since Chauhan (2003) concluded that adverse outcomes related to uterine rupture with 
TOL vary according to the time, place and size of that particular study, South African 
studies addressing VBAC would seem logical. This need for local research is 
strengthened by the paucity of recent local studies on this topic. 
 
Chris Hani Baragwanath hospital is a tertiary referral centre in the South African 
public health sector. It is also a teaching hospital affiliated to the University of the 
Witwatersrand. It remains one of the largest single obstetric units worldwide, with 
more than 20 000 deliveries per annum. About 25% of these are by CS. Therefore, the 
choice of an elective repeat caesarean section (ERCS) or a trial of labour (TOL) is of 
particular importance in our setting. 
  
VBAC has been shown to be reasonably safe and effective, with the provision of strict 
criteria for patient selection, intrapartum fetal and maternal monitoring, theatre 
facilities, blood transfusion services, and appropriately trained obstetric, neonatal, 
anaesthetic, and nursing personnel. Challenges in meeting these criteria at our facility 
include the high turnover of patients and limited personnel and equipment resources. 
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The patient load at the CHB hospital continues to rise with a growing population. The 
facilities for providing healthcare services to this community however, have not been 
upgraded accordingly. Therefore, clinical management within individual departments 
must adapt to best use the limited resources available. VBAC can be used as a 
measure to prevent increasing overall caesarean section rates. However, an 
appropriate selection of patients for TOL, to ensure a high VBAC success rate is of 
utmost importance. This would ultimately minimise maternal and neonatal morbidity 
and mortality, associated with failed VBAC and subsequent emergency repeat CS.  
 
The most recent labour ward audit at the CHB hospital showed that 13% of the ANC 
population had one or more prior CS. However, the overall VBAC rate was only 33%. 
A study at the CHB hospital to establish the current VBAC success rate was therefore 
warranted. 
 
This study would also need to identify factors associated with success or failure of 
TOL, in order to recommend changes to improve VBAC success. An analysis of 
current maternal and neonatal adverse outcomes related to TOL would also be 
necessary, for a complete assessment of safety and feasibility of a policy of VBAC, 
for suitable patients with a prior CS.  
 
Doctors and patients must be aware of the expected chance of a successful VBAC and 
the potential adverse outcomes before attempting TOL. These issues must be included 
in the counselling and decision-making process when considering TOL compared to 
ERCS. A study of this nature could provide information on these aspects that are 
relevant to our particular clinical setting and patient profiles. 
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1.3 Statement of Problem 
• The efficacy and safety of TOL and VBAC at CHB hospital have not been 
determined recently. 
• The perception that there is low VBAC success at our facility needs to be 
researched.  
• The VBAC attempt and success rate needs to be established.                 
• The assumption that offering TOL to all patients with one previous TLCS, would 
prevent increasing CS delivery rates, has not been justified in our setting. 
• The option of TOL vs. ERCS or ERCS for all patients with one previous CS needs 
to be re-evaluated in light of current VBAC success rates and potential adverse 
effects. 
 
1.4 Justification for the Study 
• A study addressing VBAC in the South African public health sector is needed, 
since recent research on this topic is limited, and it will allow for meaningful 
comparison with existing studies from developed countries. 
• These issues have significant financial and medico-legal implications, and have not 
been recently evaluated at our institution. 
• The findings and recommendations of this study would justify current and future 
departmental policies on delivery after CS, at the CHB hospital. 
• The outcomes and suggestions of this study could serve as a basis for future studies 
at this facility or others in South Africa.  
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1.5  Study Aim and Objectives 
Aim 
To assess the efficacy of TOL for patients with a prior CS and to identify predictive 
factors for VBAC success at CHB hospital. 
Objectives 
Primary objectives. 
• Establish mode of delivery. 
• Determine what proportion of eligible patients attempt TOL (by excluding 
patients with clear indications for ERCS, and those where an unplanned 
emergency event precluded TOL and resulted in an EmCS). 
• Establish the VBAC success rate of those who attempt TOL.  
Secondary objectives. 
1. Establish reasons for EmCS, ERCS, and failed VBAC.  
2. Determine the influence of the following variables on VBAC success rates: 
• Maternal age and parity 
• Birth  weight and gestational age 
• HIV serostatus  
• Antenatal care-related factors (ultrasound, hospital  booking) 
• Previous vaginal delivery (before or after previous CS) 
• Indication for previous CS 
3. Compare adverse outcomes according to the mode of delivery : 
• Maternal (death, uterine rupture or dehiscence, hysterectomy, 
haemorrhage requiring blood transfusion, maternal sepsis) 
• Neonatal (Five-minute Apgar score < 7, neonatal ICU admission, 
intrapartum fetal death or early neonatal death) 
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2. Methodology 
2.1 Study Design  
This was a retrospective descriptive study, with analytic components of delivery 
outcomes in patients with one previous caesarean section.  
2.2 Study population 
This included all patients who delivered at the Chris Hani Baragwanath hospital for 
the period of January 2003 to December 2005. This represents a low-income urban 
population attending a public hospital in Soweto, Johannesburg, South Africa. 
2.3 Sample size 
This was calculated using Epi-Info statistical software. A minimum of 326 records 
were needed to provide an estimate of VBAC success rates, with a 5% precision using 
a 95% confidence interval. A study population of 60 000 patients was required, with 
an expected prevalence of previous CS of 13% and VBAC of 33% (based on labour 
ward statistics at CHB hospital).     
2.4 Data Capture  
All data relevant to patients’ antenatal, intrapartum and postpartum care is 
handwritten. This is kept in individual hospital files, each of which is allocated a 
computer-generated random alphanumeric filing number on admission. The complete 
file is systematically stored on discharge, within the department, based on only the 
last 3 numeric digits.  
 
A screening sample of 3600 records was collected from this record storage area. We 
sampled the first six records of the first six rows (from a total of ten rows), from each 
of the ten shelves in all ten filing cabinets. Randomisation was ensured by the original 
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computer generated number allocation and the existing filing system. This systematic 
screening yielded 383 records for analysis. (Figure 1) 
 
Data from all patients with one or more previous CS was recorded and transferred 
onto a data capture sheet (Appendix 1). This was then placed on a computer database 
using Epi-Info statistical software (Appendix 3). Data capturing and transfer was 
carried out by the same researcher, in order to minimize any potential bias in 
interpretation of the written records.    
 
2.5 Variables 
 Demographic Data 
i. Age and parity 
ii. Gestation 
iii. Birth weight 
iv. HIV serostatus 
Obstetric History 
i. Previous successful VBAC 
ii. Previous  vaginal delivery  
iii. Indication for previous CS 
iv. Booked antenatal care at CHB hospital  
v. Antenatal ultrasound 
 
Primary Outcomes 
i. Final mode of  delivery   
Secondary Outcomes 
i. Reasons for ERCS, EmCS and failed VBAC 
ii. Adverse effects (maternal and neonatal) 
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2.6 Data Analysis 
Epi-Info statistical analysis software (Version 3.3.2, 2005) was utilised for initial data 
capturing and analysis. Further statistical analysis of subgroups, stratified analysis, 
and graphic representation of data was carried out using SPSS statistical software 
package (version 11.0).  
 
Presentation of descriptive statistics was done using proportions expressed as 
percentages. Continuous data were presented as means with ranges or standard 
deviations (±SD). Most variables were categorical in nature. Therefore the 
uncorrected Chi squared test (χ²) for comparison of proportions was used to evaluate 
statistical differences between groups. The odds ratio (OR) was used to assess the 
strength of the associations of the variables analysed, with a 95% confidence interval 
(CI). The Fisher’s exact test was used to evaluate statistical differences where 
numbers were inappropriately small for the χ² test. The strength of these associations 
was expressed by the relative risk (RR) with a 95% CI. The Student’s T-test was used 
to compare continuous normally distributed variables (for example, age, gestation, 
birth weight, etc), while the Mann-Whitney test was used to compare differences in 
parity.  
 
The primary outcome was final mode of delivery. This was expressed by using 
descriptive statistics such as frequencies and percentages, and included all 383 
patients in the cohort.  
 
Similar methodological steps needed to be followed in order for the results of this 
study to be comparable to others in the literature. This required the exclusion of all 
patients in whom there was a clear indication for ERCS, and all patients where an 
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unplanned emergency event precluded TOL and resulted in an EmCS, prior to a 
secondary analysis. After relevant exclusions, the sample size (n=340) was still large 
enough for statistically significant comparisons. The secondary analysis looked at 
differences between the subgroups of patients attempting TOL, i.e. successful and 
failed VBAC, in order to identify predictors of VBAC success.  
 
Demographic factors analysed included maternal age and parity, birth weight, 
gestational age, HIV seropositivity, and specific antenatal certain care related factors. 
The latter included no antenatal booking, antenatal care at a primary or secondary-
care facility other than CHB hospital, and having an antenatal ultrasound 
investigation. A stratified analysis of the effects of increasing gestation and neonatal 
birth weight on VBAC success was also carried out. Obstetric history analysed 
included previous vaginal delivery (before or after prior CS) and indications for 
previous CS. 
 
Important outliers and confounders needed to be identified and removed when 
studying complications and adverse outcomes related to mode of delivery. This was 
important in standardising our results, thereby allowing comparison of this study with 
others, both from developing and developed countries. Therefore, when analysing 
adverse events, confounding factors (severe pre-eclampsia, lack of antenatal care, 
fetal congenital abnormalities) and outliers (prematurity and low birth weight) were 
first removed. A comparison of maternal and neonatal morbidity and mortality was 
then made between ERCS and TOL. This comparison was repeated between the 
successful and failed VBAC subgroups.  
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2.7 Pilot Study  
A pilot study, using the first 100 records captured, was carried out to assess the 
feasibility of data capture and transfer. The data collection tools (Appendix 1,2 & 3) 
were modified according to the results of the pilot study, to include only variables that 
were consistently available for analysis. 
   
2.8 Ethical Considerations  
This was a retrospective record review, with no patient interaction. All data sampling 
and capture was carried out at CHB hospital in the Maternity department records 
room.  No patient identifiable data, date or time of delivery, nor health-worker 
information was recorded.  
 
Permission to access the data and use the department records room was granted by the 
CHB hospital department of Obstetrics and Gynaecology. Permission to conduct the 
study was obtained from the hospital superintendent. 
 
Ethical clearance was obtained from the Human Research Ethics Committee 
(Medical) for the University of the Witwatersrand. 
  
Protocol Number M060437, R14/49 Sayed/Buchmann. (Appendix 4) 
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3.  Results 
 
3.1 Overview 
A random sample of 3600 patient records yielded 464 with one or more prior CS. 
Records of 10 patients with second-trimester medical termination of pregnancy, and 
one postnatal referral were excluded (Figure 1). 
 
 
  
 
 
 
  
  
  
Figure 1.  Data sampling and screening to identify records suitable for analysis. 
 
*Birth weight 300-870g, 6 hysterotomies (4 intra-uterine fetal death, 1 pre-eclampsia and 1 anencephaly), and 4 
VBAC (misoprostol induction of labour for intra-uterine fetal death). 
 
Previous CSx4 
1 (0.2%) 
Previous CSx1 
383 
(84.5%) 
Sample size 
3600
3136 
Excluded 
 
No previous 
CS 
464 files 
Extracted 
453 files 
Analysed 
100% 
11 Excluded 
 
10 Termination 
of Pregnancy * 
 
1 Postnatal  Previous CSx2 
66 (14.6%) 
Previous CSx3 
3 (0.7%) 
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Delivery outcomes of the remaining 453 patients are listed in Table 1. One-third of 
patients with one or more prior CS had VBAC (152/453). Conversely, two-thirds 
(301/453) had a repeat CS. One-third of these were elective (97/301), with 45% of all 
patients with one or more prior CS having an emergency procedure (204/453). 
 
Table 1. Delivery outcomes grouped according to number of previous CS. 
 
 
3.2 Delivery outcomes  
Three hundred and eighty three records were analysed in detail (Figure 2). There were 
39 patients who had an emergency CS after an unplanned event precluding TOL 
(Table 3), and 4 patients having a clear indication for repeat CS (Table 4). From the 
remaining 340 patients who were eligible for VBAC, 287 (84.4%) attempted TOL 
(148 were successful and 139 had a failed VBAC). Fifty-three patients (15.6%) had 
ERCS. Therefore, VBAC success was 51.6% (148/287).  
 
 ERCS EmCS 
Failed 
VBAC 
Successful 
VBAC 
Total 
Previous 
CSx1 
57 
(14.9%) 
39 
(10.2%) 
139 
(36.3%) 
148 
(38.6%) 
383 
Previous 
CSx2 
37 
(56%) 
25 
(37.9%) 
0 
4 
(6.1%) 
66 
Previous 
CSx3 
2 1 0 0 3 
Previous 
CSx4 
1 0 0 0 1 
Total 97 65 139 152 453 
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Figure 2.  Methodological steps of data processing and analysis. 
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of VBAC 
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precluding TOL  
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Clear indication for 
elective CS 
 4 ERCS 
Previous CSx1
383
Eligible for TOL  
340  
241 records 
43 ERCS  
198 TOL 
Outliers 
Birth weight < 2000g 
Gestation < 32 weeks  
Confounders 
Severe pre-eclampsia 
Fetal Abnormality 
No antenatal care 
Analysis of 
delivery 
outcomes 
Maternal  and Neonatal  
morbidity &  mortality 
TOL 
287 (84.4%) 
ERCS 
53 (15.6%) 
VBAC 
success 
148  
(51.6%) 
VBAC 
failure 
139 
(48.4%) 
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3.2.1 Indications for prior CS 
Indications for the prior CS are listed in Table 2. The indications in order of 
decreasing frequency were : CPD (35%), fetal distress (14.4%), breech presentation 
(10.7%), hypertension (9.7%), twins (3.7%), failed induction of labour (IOL) (2.1%), 
other malpresentation (oblique or transverse lie 1.6%), placenta praevia (0.8%) and 
placental abruption (0.3%). The indication was unknown in 21.1% of cases.  
 
 Table 2. Indications for previous CS in patients with one prior CS. 
Indication EmCS n=39 
ERCS  
N=57 
Failed 
VBAC 
n=139 
Successful 
VBAC 
n=148 
Total  
n=383  
(%) 
Failed 
 induction of labour 
0 0 4 4 
8   
(2.1) 
Breech 4 5 10 22 
41   
(10.7) 
Malpresentation 1 2 0 3 
6   
(1.6) 
Twins 3 0 6 5 
14  
(3.7) 
Fetal distress 7 9 22 17 
55    
(14.4) 
Hypertension 7 11 9 10 
37  
(9.7) 
Placenta praevia 0 1 1 1 
3    
(0.8) 
Cephalo-pelvic 
disproportion 
12 13 65 44 
134   
(35.0) 
Placental 
abruption 
0 1 0 0 
1    
(0.3) 
Unknown 8 12 20 41 
81   
(21.1) 
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3.2.2 Indications for EmCS 
Indications for the 39 EmCS, in patients unsuitable for TOL, are listed in Table 3. 
Since the indications for EmCS were not mutually exclusive, 53 were recorded. It was 
difficult to determine from the records which of these patients had a failed TOL with a 
subsequent emergency repeat CS, or an ERCS, since patients either presented with 
spontaneous labour or required expeditious delivery. Some of this group of patients 
were further complicated by iatrogenic or spontaneous preterm delivery. Almost half 
of the patients in this subgroup (19/39) had a pregnancy complicated by hypertension. 
All of the remaining patients had other obstetric or medical contraindications to a 
vaginal delivery. We therefore excluded this subgroup from further analysis. 
 
Table 3. Indications for emergency caesarean section (EmCS), n=39. 
Indications n* 
Suspected classical / unknown scar 1 
Breech 12 
Transverse / oblique lie 2 
Twins 2 
Pre-eclampsia 16 
Eclampsia 3 
Maternal medical problem 1 
IUGR 6 
Fetal distress 6 
Cord prolapse 3 
Suspected abruptio placenta 1 
* There were 53 indications recorded as 14 patients had more than 1 indication for EmCS. 
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3.2.3 Indications for ERCS 
Indications for the 57 ERCS are listed in Table 4. Patients with clear indications for 
ERCS were excluded from further analysis (2 twin gestations and 2 breech 
presentations).  
 
Table 4. Indications for elective caesarean section (ERCS), n=57. 
Indications n  
Patient request 12 
Post dates pregnancy 19 
PIH 16 
Twins * 2 
Breech * 2 
IUGR 2 
Fetal macrosomia 4 
* Excluded from final analysis 
 
3.2.4 Reasons for failed VBAC 
Indications for emergency repeat CS, following failed VBAC, are shown in table 5. 
Four patients from this subgroup of 139 had more than one indication. Prolonged 
latent phase of labour (PLPL) (33.8%), poor progress in active phase of labour 
(24.5%), suspected fetal distress (27.3%), and prelabour rupture of membranes 
(PROM) (6.5%) were the most common reasons for failed VBAC. 
 
Augmentation of labour in patients with a prior CS is not practised at CHB hospital, 
therefore all TOL with PLPL and PROM were delivered by emergency CS. 
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Table 5. Indications for emergency repeat CS after failed VBAC (n=139). 
Indication n   % of VBAC Failure 
Prelabour rupture of membranes  9 6.5 
Prolonged latent phase of labour  47 33.8 
Poor progress in  active phase 34 24.5 
Poor progress in 2nd stage 8 5.6 
Fetal distress 38 27.3 
Antepartum haemorrhage 3 2.2 
Suspected uterine rupture 4 2.9 
 
3.3 Predictors of VBAC success 
3.3.1  Demographic Factors 
Table 6 demonstrates that there was no difference in maternal age between the 
successful and failed VBAC groups. There was however, a significantly higher parity, 
lower gestation, and lower birth weight for successful compared to failed VBAC. 
 
Table 6. Demographic variables affecting VBAC success.  
 Successful VBAC   
n=148 
Failed VBAC  
n=139 P value 
Age 
mean±SD 
29.5 (±5.9) 28.3 (±5.5) 0.06 
Parity 
Mean (range) 
1.80 (1-5) 1.43 (1-4) <0.001 
Gestational age 
mean±SD  
37.2 (±3.0) 38.7 (±2.0) <0.001 
Birth weight (g) 
mean±SD 
2909 (±654) 3207 (± 507) <0.001 
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At a gestation <34 weeks the VBAC success rate is 89%, and this decreases to 56% at 
≤39 weeks. At >40 weeks gestation the ratio of VBAC success to failure reverses 
(33%). This difference was significant (p<0.001) on stratified analysis (Figure 3). 
> 4037 - 3934 - 36< 34
100
80
60
40
20
0
VBAC
Success
Failure
53
65
19
26
84
20
16
 
Figure 3.  VBAC success according to gestation intervals (p<0.001). 
 
The VBAC success to failure pattern is similar for birth weight (Figure 4). VBAC 
success at a birth weight <2000g is 93% and declines to 52% at ≤3499g. The ratio is 
reversed at a birth weight >3500g (38%), and is low at >4000g (22%). This difference 
was also significant (p<0.001) on stratified analysis. 
> 4000g
3500 - 3999g
3000 - 3499g
2500 - 2999g
2000 - 2499g
< 2000g
60
50
40
30
20
10
0
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35
50
30
8
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54
42
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Figure 4.   VBAC success according to birth weight intervals (p<0.001). 
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Table 7 demonstrates that in this study, HIV seropositivity, and certain care related 
factors did not differ significantly between the VBAC success and VBAC failure 
groups. (All p>0.05 in this analysis.) 
 
Table 7. The effect of HIV seropositivity and antenatal care-related variables 
on VBAC Success. 
 
 
3.3.2 Obstetric history 
The presence of a previous vaginal delivery before the first CS, or a previous vaginal 
birth after the first CS (VBAC) proved to be independently predictive for successful 
VBAC (OR 2.32 and 1.93 respectively). The relationship was explored further by 
combining the two individual variables in a statistical analysis. This identified the 
patient with no prior vaginal deliveries as having the lowest likelihood of successful 
VBAC (OR 0.34; 95% CI 0.20-0.58) (Table 8). 
 
 
 
 Failed 
n=139 (%) 
Successful   
n=148 (%) OR    (95% CI) p value 
HIV seropositive 44 (31.7) 39 (26.4) 0.77  (0.45–1.33) 0.322 
No antenatal booking 5 (3.6) 11 (7.4) 2.15   (0.67-7.32) 0.157 
Primary or 
secondary level care 
only   
25 (18.0) 23 (15.5) 0.84   (0.43-1.63) 0.579 
Presence of antenatal 
sonar 
72 (51.8) 70 (47.3) 0.84  (0.51-1.36) 0.446 
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Table 8. The effect of previous vaginal delivery on VBAC success. 
 
 
 
 
Failed VBAC  
n=139  (%) 
Success VBAC 
  n=148 (%) 
OR   
(95% CI) p value 
Previous 
vaginal delivery 
22(15.8) 45(30.4) 
2.32 
(1.31-4.13) 
0.004 
Previous VBAC 18(12.9) 33(22.3) 
1.93 
(1.03-3.62) 
0.038 
No previous 
vaginal delivery  
103(69.6) 73(49.3) 
0.34 
(0.20-0.58) 
<0.001 
 
The indications for previous CS in patients who attempted TOL are summarised in 
Table 9. Previous CPD was a negative predictor of VBAC success (OR 0.48; 95% CI 
0.30-0.78), while a previous CS for malpresentation was a positive predictor (OR 
2.62; 95% CI 1.15-6.12). The effect of previous CS for fetal distress or hypertension 
was not statistically significant. 
 
Table 9. The effect of indications for previous CS on VBAC success. 
 
Indications for 
prior CS 
Failed  
n=139 (%) 
Successful    
n=148 (%) 
OR 
 (95% CI) 
p value 
Cephalo-pelvic 
disproportion 
 
65 (46.8) 44 (29.7) 0.48 (0.30 – 0.78) 0.003 
Fetal distress 22 (15.8) 17 (11.5) 0.69          (0.35 – 1.36) 0.283 
 Malpresentation 10 (7.2) 25 (16.9) 2.62          (1.15 – 6.12) 0.012 
Hypertension       9 (6.5) 10 (6.8) 1.05         (0.38 – 2.91) 0.924 
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3.4 Maternal and neonatal adverse outcomes 
Although this study was not designed to show differences in adverse maternal or 
neonatal outcomes, no study of this nature is complete without some mention of 
morbidity and mortality. 
 
The sample included no maternal deaths. There were two symptomatic uterine 
ruptures in patients attempting TOL and therefore, a 0.7% uterine rupture rate (2/287). 
Similarly, there were two asymptomatic uterine dehiscences in patients with failed 
VBAC. There were four hysterectomies, 2 associated with uterine rupture following 
failed TOL, one with haemorrhage after failed TOL and a subsequent emergency 
repeat CS, and one with haemorrhage following an EmCS in a patient not suitable for 
TOL. This represents a 1% hysterectomy rate (4/383). 
 
Before analysing neonatal morbidity or mortality however, it was necessary to remove 
the confounding effects of prematurity, in order to isolate the effects of TOL and 
ERCS on these outcomes. Gestational age distribution in this study was skewed 
towards the right (Figure 5), with a mean (±SD) of 37.8 (±2.9) weeks. Therefore, 
patients with a gestational age of more than 2 standard deviations below the mean, i.e. 
<32 weeks, were excluded from the final analysis of adverse events.  
 
Since gestational age and birth weight correlated in only 74.3% of cases in this study 
(Pearson correlation r = 0.743, p<0.01), we analysed these two variables separately. In 
order to avoid the confounding effects of low birth weight on adverse neonatal events, 
the final analysis was confined to women with a gestational age of 32 weeks or more, 
as well as a birth weight of  2000g or more.  
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Figure 5. Gestational age distribution in patients with one previous CS. 
 
Birth weight also deviated from the normal distribution curve, and was skewed to the 
right (Figure 6). The mean (±SD) for birth weight was 2993g (±658). Therefore 
patients with birth weights <2000g (less than 1.5 SD from the mean) were excluded.  
g
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Figure 6. Birth weight distribution in patients with one previous CS. 
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Demographic factors such as patients not booking for antenatal care, and antenatal 
care at lower-level facilities than CHB hospital, were identified as possible 
confounders. Three neonates with hydrocephalus were also identified post partum. 
These patients were therefore excluded from the final analysis. 
 
After removing all identified outliers and possible confounding factors, we were left 
with 241 patients (from an initial 383) comprising ERCS (n=43) and TOL (n= 198). 
The TOL group was further divided into two subgroups, successful and failed VBAC 
(n=99 and n=99 respectively), for further analysis of adverse outcomes. 
 
Adverse events were analysed looking in turn at maternal (Table 10) and then 
neonatal (Table 11) indicators of morbidity and mortality. Outcomes are listed both 
before and after removing confounders, outliers, and patients that were not eligible for 
TOL, in order to allow for comparison. Statistical analysis however, was only carried 
out on the corrected variables. These included differences between the ERCS (n=43) 
and the TOL (n=198) groups, and differences between the successful (n=99) and 
failed (n=99) VBAC groups. 
 
The analysis showed no maternal morbidity or mortality (0/43) in the ERCS group 
when compared to the TOL group (16/198). This suggest that patients who elected to 
have TOL at more than 32 weeks gestation or with a neonatal birth weight of more 
than 2000g, had an increased chance of having one or more indicators of morbidity. 
Therefore, the relative risk of overall maternal morbidity for TOL in this study, was 
RR of 1.24 (95% CI of 1.16-1.32, Fisher exact p=0.038).  
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Table 10. Adverse Maternal outcomes according to mode of delivery.  
 
* After correcting for confounding factors including severe pre-eclampsia, eclampsia, 
congenital abnormalities, gestation <32 weeks, birth weight <2000g and other obstetric 
contraindications to TOL. 
 
This effect was more marked (RR 1.87) when comparing maternal morbidity 
indicators between the failed and successful VBAC groups, (14/99 compared to 2/99). 
(95% CI 1.47 -2.39, χ² =9.79, p=0.002). This suggests that the patient who attempts 
TOL and fails has an increased risk for maternal morbidity.  
 
Indicators of serious maternal morbidity included two uterine ruptures and two 
hysterectomies (failed VBAC). These numbers were too small for meaningful 
individual statistical analysis. The analysis of other individual indicators of maternal 
morbidity (ERCS vs. TOL and failed vs. successful VBAC) were also not significant 
(Fisher exact test, p>0.05). 
Observed Corrected * Indicators 
of 
maternal 
morbidity EmCS 
n=39 
ERCS 
n=57 
VBAC 
failure 
n=139 
VBAC 
Success 
n=148 
ERCS 
n=43 
VBAC 
failure 
n=99 
VBAC 
Success 
n=99 
Uterine 
rupture 
0 0 2 0 0 2 0 
Uterine 
dehiscence 
0 0 2 0 0 2 0 
 
Hysterectomy 
 
1 0 3 0 0 2 0 
Blood 
transfusion 
2 0 6 1 0 4 0 
 
Sepsis 
0 0 5 3 0 4 2 
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Table 11. Adverse Neonatal outcomes according to mode of delivery. 
 
*After correcting for confounding factors including severe pre-eclampsia, eclampsia, 
congenital abnormalities, gestation <32 weeks, birth weight <2000g and other obstetric 
contraindications to TOL. 
 
TOL patients had a RR of 1.23 of having an adverse neonatal outcome when 
compared with ERCS patients (15/198 compared to 0/43), 95% CI of 1.16-1.32, 
Fisher exact p=0.048. While there was an apparently lower adverse neonatal outcome 
in the failed compared to the successful VBAC group (6/99 compared to 9/99), this 
was not significant (p=0.420). 
 
Analysis of individual indicators of neonatal morbidity between both the ERCS and 
TOL groups, and between the failed and successful VBAC groups, were not 
significant (Fisher exact test, p>0.05). 
 
Observed Corrected * Indicators 
of 
neonatal 
morbidity EmCS 
n=39 
ERCS 
n=57 
VBAC 
failure 
n=139 
VBAC 
success
n=148 
ERCS 
n=43 
VBAC 
failure 
n=99 
VBAC 
success 
n=99 
Five-minute 
Apgar 0-3 
0 0 1 1 0 1 
 
0 
 
 
Five-minute 
Apgar 4-6 
 
4 1 3 7 0 2 4 
Neonatal 
ICU 
admission 
14 3 4 19 0 3 4 
Intrapartum 
fetal 
death 
0 0 2 1 0 0 1 
Early 
neonatal 
death 
0 0 0 2 0 0 0 
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4. Discussion 
Research with regard to the elective CS versus trial of labour debate, for suitable 
patients with prior CS, is very relevant in the South African setting since there are 
only a few small studies in the literature from developing countries on this topic (Van 
der Walt 1994, Tripathi 2006). 
 
Chris Hani Baragwanath hospital has a massive patient load with over 20 000 
deliveries per annum at present. It serves a low-income urban population. This 
retrospective cohort study represents a 6% random sample over a three year period 
(January 2003 to December 2005), from a single tertiary referral centre in the South 
African public health sector. With a current CS rate of 25% of all deliveries at our 
hospital, VBAC remains an important means of attempting to stabilise the increasing 
CS rate.  
 
While the private health sector in South Africa mirrors developed countries in terms 
of resources available, the public health sector remains under resourced both in terms 
of personnel and in terms of equipment. It is therefore inappropriate for developing 
countries to rely on evidence from developed countries, in order to plan healthcare 
services for our patients with previous CS. Furthermore, adverse outcomes related to 
uterine rupture after TOL, are dependant on time, place and size of the population 
studied (Chauhan 2003). This would imply that it is imperative to repeatedly analyse 
the outcomes of VBAC in South Africa. 
 
This study provides information that is relevant to our unique patient profiles and the 
various constraints under which we work in the South African public health sector.  
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We have shown that, contrary to the pattern seen in the developed world, a larger 
percentage of our patients with one prior CS (74.9%) opted for TOL in the next 
pregnancy. By comparison, the VBAC attempt rate was 60.6% in Rageth’s study from 
Switzerland (1999), 52.9% in McMahon’s study from Canada (1996) and 53.1% from 
Landon’s study in the USA (2004). 
 
This might be one of the reasons why VBAC success is lower than expected in this 
study (52% compared to 60-80% from other studies). This also meant that just under 
half (46.5%) of all patients with a prior CS had an emergency CS.  
 
In the literature review, it was found that emergency repeat CS in patients with a prior 
CS is associated with complications, resulting in increased maternal and neonatal 
morbidity. Consequences like emergency after-hours anaesthetic and theatre 
requirements, maternal high-care or ICU admissions, long neonatal admissions to ICU 
and the incalculable costs of long-term neonatal morbidity secondary to neurological 
disabilities, translate into significantly increased costs to the health-care system. 
Therefore, a high emergency CS rate is of particular concern in our setting. 
 
Furthermore, at least 40% of patients having an emergency CS (PROM or PLPL) may 
have been amenable to induction or augmentation of labour with oxytocin (SOGC 
guidelines 2004). A further 24.5% of failed TOL patients (those with poor progress in 
active phase) may also have been considered for oxytocin augmentation. A small case 
control study previously carried out at the CHB hospital (Van Gelderen 1986) 
recommended augmentation of labour in selected patients having TOL.  
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However, inadequate staffing for one to one intrapartum care and insufficient cardio-
tocograph machines for continuous electronic fetal monitoring meant that this is not 
feasible at present at CHB hospital. Had this option been available, VBAC success 
may have been improved in this subgroup of patients. 
 
There were no differences between successful and failed VBAC in terms of maternal 
age, HIV seropositivity, hospital–based antenatal care and the presence of an antenatal 
ultrasound examination. However, as expected, those with successful VBAC had a 
higher parity, lower birth weight, and lower gestation at delivery when compared to 
those with failed VBAC. Our finding of increased VBAC failure with increasing birth 
weight or gestation matches the findings of existing studies. (Zelop 2001 and Elkousy 
2003) 
 
Positive predictors of VBAC success that match findings in the literature review 
included a previous vaginal birth both before and after the initial CS, a previous CS 
for malpresentation, and a gestation ≤ 39 weeks at delivery. (Zelop 2000, Macones 
2005, Landon 2005 and Cahill 2006) Conversely, negative predictors of VBAC 
success in this study were patients with no prior vaginal delivery, and a previous CS 
for CPD, which also reflect existing findings.  
 
We found that VBAC had a lower success rate at a birth weight >3500g. This may be 
true for the South African setting when considering Van der Walt’s study (1994) that 
showed similar findings for birth weight >3200g. Similarly, Tripathi (2006) reported 
low VBAC success at a birth weight >3000g in their study from India. Studies in the 
literature that were conducted in developed countries only reported low VBAC 
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success at birth weights over 4000g (Landon 2005) and some of up to 4250g (Zelop 
2001, Elkousy 2003).  
 
There was no maternal mortality in this study. There was a 0.7% uterine rupture rate 
(identified separately from asymptomatic uterine dehiscence, which also had a 
frequency of  0,7%). These adverse outcomes occurred in patients who attempted 
TOL and had a failed VBAC.  There was a 1% hysterectomy rate for all patients with 
one prior CS. This uterine rupture and hysterectomy rate is comparable however, to 
all large studies cited in the literature review.  
 
In this study TOL compared to ERCS had an increased risk of having a maternal 
adverse outcome, including uterine rupture, uterine dehiscence, hysterectomy, 
haemorrhage requiring blood transfusion or maternal sepsis.  
 
Similarly, TOL had an increased risk of a neonatal adverse outcome, including a five-
minute Apgar score<7, neonatal ICU admission, intrapartum fetal death or early 
neonatal death. Failed VBAC however, had almost double the risk of maternal 
morbidity when compared to successful VBAC. This was statistically a very 
significant finding. The results of morbidity and mortality in this study do not differ 
from evidence in the current literature. 
 
4.1 Implications for research 
The world literature still lacks evidence from large, prospective, randomised 
controlled trials with respect to VBAC. The current evidence determining outcomes, 
risk factors and current practice trends comes from the analysis of relatively large 
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databases. It remains important however, that we strive towards prospective 
randomised trials, to eliminate bias from the results. 
 
Unfortunately, even this may not give us all the answers to the dilemma of elective 
caesarean delivery versus attempted vaginal birth after caesarean section. It is not 
always possible to extrapolate findings from studies in well-staffed and well-
resourced centres to smaller hospital or less privileged institutions in the developing 
world.  
 
Ideally however, South Africa requires a collaborative, multi-centred, prospective 
randomised controlled trial, which can assess the effects of demographic data and 
obstetric history on VBAC success rates and associated maternal or neonatal adverse 
outcomes in our setting. Until then, further prospective studies looking at VBAC in 
South Africa, at this and other centres, will continue to add to evidence on how best to 
manage this issue of growing importance. 
 
4.2 Implications for practice 
This study is reassuring that a policy of VBAC for suitable patients with one prior low 
transverse CS, is relatively safe at our institution. However, the failed VBAC rate 
remains high. An improvement in the VBAC success rate would be the key to 
minimising maternal and neonatal morbidity and mortality.  
 
Firstly, a more stringent selection of patients for TOL is necessary. This means a 
change in policy for local primary and secondary level facilities to refer patients with 
a prior CS well before 40 weeks of gestation to CHB hospital for an elective CS. It 
also implies that the patient with an estimated birth weight in excess of 3500g should 
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be cautioned about the increased chances of a failed VBAC, with its associated 
complications. Patients with no previous vaginal delivery must be informed about the 
low likelihood of VBAC success, particularly in those with a prior CS for CPD. 
 
Secondly, improved staff and equipment quotas might allow for a change in policy 
towards selective oxytocin induction or augmentation of labour, in patients who 
clinically do not have cephalo-pelvic disproportion, and present with prelabour 
rupture of membranes or prolonged latent phase of labour. The small increase in 
uterine rupture (Landon 2004) will need to be balanced against reducing the current 
high emergency CS rate. 
 
4.3 Limitations  
The retrospective nature of this study introduces a number of limitations. Only 
information clearly and consistently recorded in the patients’ hospital file and 
antenatal card was available for analysis. This resulted in a number of important 
variables been left out of the study, including maternal body mass indices, pre-
delivery birth weight estimates, cervical dilatation on admission, labour duration and 
long term neonatal data 
 
It is inappropriate to comment on the influence of HIV on VBAC without assessing 
patients’ immune status independent of seropositivity. This meant that we required 
CD4 counts and information on anti-retroviral therapy, which was unfortunately not 
available in a large proportion of the patients studied. With the introduction of a full-
scale anti-retroviral therapy roll-out program, this can be rectified in future studies. 
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Our data on maternal and neonatal adverse outcomes must be interpreted with caution, 
since very large sample sizes are necessary to adequately assess the infrequent but 
serious events that lead to death and disability, in particular uterine rupture following 
TOL. This study was designed to show differences in mode of delivery and 
subsequently predictive factors for VBAC success. It remains underpowered to show 
differences in morbidity and mortality.  
 
The findings of this study should only be extrapolated to other facilities in South 
Africa with similar resources and personnel, in the context of the availability of 
emergency CS facilities. 
 
4.4 Conclusion 
The VBAC success rate at the CHB hospital is lower than those reported from large 
cohorts in developed countries. A large proportion of our patients attempt TOL, with 
only a small percentage having ERCS.  
 
This implies that a large proportion of patients are having an emergency CS after a 
failed VBAC. Patients having TOL in this study had an increased likelihood of 
maternal and neonatal morbidity, with a significantly higher maternal morbidity in the 
failed compared to the successful VBAC group. It is therefore possible that an 
increased number of patients should be having ERCS. 
 
Antenatal counselling of patients needs to highlight the increased risk of maternal and 
neonatal morbidity with TOL compared to ERCS. The relative safety of VBAC after 
one prior caesarean section therefore, can only be justified if ongoing attempts are 
made to reduce the chances of a failed VBAC.  
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This implies that a more stringent selection of patients for TOL is warranted. This 
study suggests that VBAC success was higher in patients with birth weights <3500g, 
gestational age ≤ 39 weeks, prior vaginal delivery (before or after previous CS) and in 
those patients with a previous CS for malpresentation.   
 
A possible change in policy toward selective induction of labour in patients with 
prelabour rupture of membranes, or augmentation of labour in those with prolonged 
latent phase of labour, can only be considered if staffing and equipment shortages are 
corrected.  
 
Overall the research is reassuring of the feasibility of an ongoing policy, at Chris Hani 
Baragwanath hospital, of trial of labour for suitable patients with one previous 
caesarean section. 
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Appendix 1  :  Data capture sheet. 
  
Record 
No. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Delivery plan 
TOL / ERCS         
Reason for 
ERCS         
Age 
 
 
        
Gestation 
 
 
        
HIV 
 
 
        
Fetal 
Weight 
 
        
Previous 
Vaginal 
delivery 
 
        
Previous 
VBAC 
 
 
        
Indication  
previous CS 
 
 
        
Adverse 
effects 
 
 
        
Reasons for 
Failed VBAC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Final mode of 
delivery         
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Appendix 2   :  Key to data capture sheet. 
 
Key to Data Capture Sheet 
 
Indications for previous CS 
A- Dystocia ( specify : Cephalo-Pelvic Disproportion (CPD), fetal 
macrosomia, slow progress, failed IOL, failed assisted delivery) 
B- Malpresentation ( specify : Breech, Transverse) 
C- Suspected fetal Distress 
D- Other fetal or maternal indication ( specify : antepartum haemorrhage 
(APH), Pre-eclampsia, Intra-uterine Growth Restriction (IUGR), 
Twins) 
Adverse effects 
A- Maternal death 
B- 5 min Apgar score 0-3 
C- 5 min Apgar score 4-7 
D- Neonatal ICU admission 
E- Fetal  intrapartum death  
F- Neonatal death 
G- Uterine rupture 
H- Uterine dehiscence 
I- Hysterectomy 
J- Haemorrhage  
K- Blood transfusion 
L- Maternal sepsis 
Reasons for failed VBAC 
A- PROM 
B- PLPL 
C- Poor progress in labour 
D- Failed assisted delivery 
E- Suspected fetal distress 
F- Suspected uterine rupture 
 
Final mode of delivery 
A- VBAC 
B- ERCS 
C-  Failed VBAC   
D - Emergency CS 
E- Ventouse Assisted VBAC  
F- Forceps Assisted VBAC 
 
 Reasons for ERCS 
A- Maternal request 
B- Post dates 
C- Maternal medical condition 
D- Fetal condition 
(medical/malpresentation/ 
multiple gestation) 
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Appendix 3 : Epi-Info computer data capture sheet. 
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Appendix 4 : Ethics clearance certificate 
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